Manipal Health Enterprises receives Sebi approval for ₹8,000 crore IPO
Issue comprises fresh equity issue and offer-for-sale; proceeds to be used for debt repayment and Sahyadri Hospitals stake acquisition
Bengaluru-based Manipal Health Enterprises has received the final approval from the Securities and Exchange Board of India (Sebi) for its initial public offering (IPO).
The company had filed its draft IPO papers with Sebi on March 25, 2026.
The IPO comprises a fresh issue of equity shares aggregating up to ₹8,000 crore and an offer-for-sale (OFS) of up to 43,227,668 equity shares by promoters Imperius Healthcare Investments Pte. Ltd and Manipal Education and Medical Group India Private Limited.
The offer-for-sale also includes equity shares being sold by investors TPG SG Magazine Pte. Ltd, Seventy Second Investment Company LLC, Ammar Sdn Bhd, Novo Holdings Invest Asia A/S and Phoenix Bear Investments, LLC.
According to the company, proceeds of ₹5,378 crore from the fresh issue will be utilised towards repayment or prepayment, in full or in part, of certain outstanding borrowings and accrued interest availed by its material subsidiary, Manipal Hospitals Private Limited.
An amount of ₹574 crore from the fresh issue will be used for the acquisition of the minority stake in the company’s step-down subsidiary, Sahyadri Hospitals Private Limited. The remaining proceeds will be used for general corporate purposes.
The company, in consultation with the book-running lead managers, may also consider a pre-IPO placement of up to ₹1,600 crore. If the pre-IPO placement is completed, the size of the fresh issue will be reduced accordingly.
- Advertisement -